Diagnosis and classification of nonalcoholic fatty liver disease and
In current medical practice as discussed here
Deciphering non-alcoholic fatty liver disease through metabolomics
(C) Lipid geometry determines membrane biophysical properties such as integrity
Considering Pharmaceutical Royalties
But licensing as considered here is primarily about granting rights under patent protection. This is a (basically not very good) reason to limit the.
